Clinical Trials Browser

Phase 2 × OTHER × PT-100 dipeptide × Clear all

NCT04171219 2025-05-16

Talabostat and Pembrolizumab for the Treatment of Advanced Solid Cancers

Phase 2 Terminated

31 enrolled 15 charts

Other solid neoplasm

Advanced Malignant Solid Neoplasm

NCT00489710 2023-08-22

Talabostat in Treating Patients With Metastatic Kidney Cancer

Phase 2 Withdrawn

Carcinoma, Renal Cell, Kidney Neoplasms